Mitochondrial Fission in Neurodegeneration describes a key molecular or cellular mechanism implicated in neurodegenerative disease. This page provides a detailed overview of the pathway components, signaling cascades, and their relevance to conditions such as Alzheimer's disease, Parkinson's disease, and related disorders.
Mitochondrial fission is the process by which mitochondria divide and fragment from an interconnected network into discrete organelles[1]. This dynamic process is essential for mitochondrial quality control, enabling the removal of damaged mitochondrial segments via mitophagy, distribution of mitochondria within neurons, and adaptation to metabolic demands. Dysregulation of fission contributes to mitochondrial dysfunction, bioenergetic failure, and neuronal death in neurodegenerative diseases. [@mitochondrial2024]
- Cytosolic GTPase that translocates to mitochondria during fission
- Forms ring-like structures around mitochondria constricting the membranes[1]
- Recruited by adaptor proteins on the outer mitochondrial membrane
- Post-translational modifications regulate its activity (phosphorylation, sumoylation, ubiquitination)
- FIS1: Outer membrane protein serving as DRP1 receptor
- MFF: Primary DRP1 receptor, essential for peroxisomal and mitochondrial fission
- MiD49/MiD50: Additional DRP1 receptors with tissue-specific expression
- ER tubules wrap around mitochondria at fission sites
- Calcium signaling regulates ER-mitochondria contact formation
- Actin polymerization provides mechanical force for constriction
- Increased fission in AD brains correlates with disease severity[2]
- Aβ promotes DRP1 recruitment to mitochondria
- Tau pathology enhances fission through GSK3β-mediated DRP1 phosphorylation
- Excessive fission leads to mitochondrial fragmentation and energy deficits
- PINK1/Parkin pathway regulates fission as part of mitophagy[4]
- Mutations in PINK1 or PRKN cause early-onset PD with mitochondrial dysfunction
- DRP1 inhibitors show protective effects in PD models
- Dopaminergic neurons are particularly vulnerable to fission dysregulation
- SOD1 mutations alter mitochondrial dynamics toward fission
- TDP-43 pathology disrupts DRP1 localization
- Increased fission in motor neurons precedes degeneration
- Fission inhibitors protect against ALS-related mitochondrial dysfunction
- Mutant huntingtin promotes excessive fission
- DRP1 hyperactivity contributes to striatal neuron vulnerability
- Fis1 expression increased in HD models and patients
- Fission blockade reverses mitochondrial deficits in HD models
- Mdivi-1: Small molecule inhibitor of DRP1 GTPase activity[3]
- P110: Specific DRP1 inhibitor reducing fission without affecting fusion
- Concerns about long-term inhibition due to essential physiological functions
- Antisense oligonucleotide approaches to reduce Fis1 expression
- Small molecule modulators of Fis1-DRP1 interaction
| Approach |
Rationale |
Status |
| Fission inhibitors + mitophagy enhancers |
Coordinate quality control |
Preclinical |
| DRP1 inhibitors + metabolic modulators |
Restore energy balance |
Research |
| Fission + fusion balancing |
Optimize dynamics |
Experimental |
- Electron microscopy: Direct visualization of mitochondrial morphology
- Live-cell fluorescence microscopy: Time-lapse analysis of fission events
- Super-resolution microscopy: Nanoscale fission site identification
- DRP1 phosphorylation status (Ser616 vs Ser637)
- FIS1, MFF protein levels
- OPA1 long/short isoform ratio (fusion:fission balance)
- Mitochondrial network analysis using skeletonization algorithms
- Mitochondrial size distribution quantification
- ATP production and mitochondrial membrane potential measurement
The dynamic equilibrium between fusion and fission determines mitochondrial morphology:
Fusion (MFN1/2 + OPA1) ←→ Fission (DRP1 + FIS1/MFF)
| Disease |
Primary Defect |
Resulting Morphology |
| AD |
Fission increase |
Fragmented |
| PD |
Variable |
Fragmented |
| ALS |
Fission increase |
Fragmented |
| HD |
Fission increase |
Fragmented |
Restore optimal dynamics rather than completely blocking fission, as both fusion and fission are essential for mitochondrial health.
- Cell-type specificity: Understanding why specific neurons are vulnerable to fission defects
- Temporal targeting: Optimal timing of intervention during disease progression
- Delivery methods: Targeting fission modulators to the CNS
- Biomarkers: Non-invasive markers of mitochondrial dynamics status
DRP1 activity is tightly regulated by multiple post-translational modifications that integrate cellular signaling cues:
Phosphorylation:
- Ser616 (activation): Phosphorylated by CDK1/2 during mitosis and by ERK1/2 in response to growth factors
- Ser637 (inhibition): Phosphorylated by PKA, dephosphorylation by calcineurin activates DRP1
- Ser40 (inhibition): AMPK-mediated phosphorylation inhibits fission under energy stress
Sumoylation:
- SENP5-mediated sumoylation stabilizes DRP1 on mitochondria
- Promotes fission under stress conditions
- Dysregulated in AD and PD
Ubiquitination:
- VCP/p97-mediated extraction of DRP1 for degradation
- Parkin ubiquitinates DRP1 during mitophagy
- Mitochondrial quality control pathways intersect with fission machinery
¶ Calcium and Calcineurin Signaling
Cytosolic calcium dynamics directly regulate mitochondrial fission:
- Elevated calcium activates calcineurin, which dephosphorylates DRP1 at Ser637
- Activated DRP1 translocates to mitochondria, promoting fission
- ER-mitochondria calcium transfer at MAMs (mitochondria-associated membranes) locally regulates fission
- Calcium dysregulation in neurodegenerative diseases hyperactivates this pathway
¶ AMPK and Energy Sensing
AMPK monitors cellular energy status and regulates fission:
- Energy deficit (low ATP/AMP ratio) activates AMPK
- AMPK phosphorylates DRP1 at multiple sites to promote fission
- Fission enables mitochondrial turnover to restore energy balance
- In AD, impaired AMPK signaling contributes to defective fission
ER tubules physically wrap around mitochondria at fission sites:
- ER-mitochondria contacts span 10-30 nm
- Multiple ER-mitochondria tethering proteins maintain contact
- Calcium signaling at these sites regulates fission machinery recruitment
| Tether |
Function |
Disease Relevance |
| VAPB-PTPIP51 |
ER-mitochondria link |
Disrupted in ALS |
| Mfn2 |
Tethering + fusion regulator |
Reduced in AD |
| IP3R-GRP75-VDAC |
Calcium transfer |
Dysregulated in PD |
| BAP31 |
ER stress sensor |
Activated in neurodegeneration |
Force generation for membrane constriction:
- ER-associated actin polymerization provides mechanical force
- Myosin II recruitment to fission sites
- Formin-mediated actin nucleation at contact sites
- Actin depolymerization blocks fission independent of DRP1
Neurons present unique fission requirements[@singh2024]:
- Mitochondria must be sized to traverse axonal diameters
- Fission enables axonal distribution and presynaptic targeting
- Synaptic activity modulates axonal fission rates
- Defects impair synaptic mitochondrial replenishment
Spatial regulation:
- Fission biased toward branch points and varicosities
- Local calcium signals trigger axonal fission
- Synaptic vesicle recycling zones are fission hotspots
Dendritic mitochondria show compartment-specific fission:
- Spine-targeted mitochondria require fission for entry
- Branch point fission enables dendrite penetration
- Activity-dependent fission shapes spine mitochondrial content
- Dysregulated fission contributes to spine loss in AD
Presynaptic terminals have specialized fission dynamics:
- High energy demand at terminals requires dynamic fission
- Synaptic activity increases fission frequency
- Fission enables rapid mitochondrial replacement
- Synaptic mitochondrial deficits correlate with neurotransmission failure
OPA1 (optic atrophy 1) mediates mitochondrial fusion[@kumar2025]:
- Long OPA1 isoforms promote inner membrane fusion
- OPA1 cleavage by OMA1 produces short isoforms
- AD-related stress increases OPA1 cleavage
- Imbalanced OPA1 processing shifts equilibrium toward fission
| Feature |
AD |
PD |
ALS |
HD |
| DRP1 levels |
↑ |
↑/↔ |
↑↑ |
↑↑ |
| OPA1 cleavage |
↑ |
↑ |
↑ |
↑ |
| FIS1 expression |
↑ |
↑ |
↑ |
↑ |
| MFN1/2 levels |
↓ |
↓ |
↓ |
↓/↔ |
| Morphology |
Fragmented |
Variable |
Fragmented |
Fragmented |
Modulating the balance rather than absolute fission:
- Restoring fusion capacity alongside inhibiting excessive fission
- Combination approaches targeting both processes
- Cell-type specific targeting required
- Temporal considerations for intervention timing
¶ Cardiolipin and Membrane Remodeling
Phospholipid dynamics regulate fission[@johnson2025]:
- Cardiolipin normally resides in inner mitochondrial membrane
- Externalization to outer membrane recruits DRP1
- Oxidative stress promotes cardiolipin externalization
- Barth syndrome-related cardiolipin defects impair fission
Fission proteins sense membrane curvature:
- DRP1 PRE domains bind curved membranes
- INF2-formin complexes generate curvature
- Peripheral proteins shape fission sites
- Curvature defects contribute to disease phenotypes
- p110 peptide: Blocks DRP1-FIS1 interaction specifically
- DRP1-blocking peptides: Cell-penetrating fission inhibitors
- Mitochondrial-targeted peptides: Localized delivery to CNS
- CRISPR-dCas9 approaches to modulate DRP1 expression
- ASOs targeting DRP1 splice variants
- AAV-mediated delivery of dominant-negative DRP1
- miRNA-based fission regulation
| Compound |
Target |
Status |
Notes |
| Mdivi-1 |
DRP1 GTPase |
Preclinical |
CNS delivery challenge |
| P110 |
DRP1-FIS1 |
Preclinical |
More selective |
| Dynasore |
DRP1 |
Research |
Broader dynamin inhibition |
| YY1-33 |
DRP1 sumoylation |
Experimental |
Enhances sumoylation |
- Fission inhibitors + metabolic enhancers
- Fission modulation + antioxidant treatment
- Fission targeting + tau/α-synuclein clearance
- Fusion-promoting compounds alongside fission inhibitors
Recent progress has accelerated fission-targeted therapy development:
Preclinical Candidates:
- Drp1-ASO: Antisense oligonucleotides reducing DRP1 expression
- mitochondria-p110: Peptide disrupting DRP1-FIS1 binding
- HDL-DRP1: Mitochondria-penetrating DRP1 inhibitor
Translation Challenges:
- CNS delivery remains the primary barrier
- Acute vs chronic dosing considerations
- Selectivity for disease-associated fission vs physiological fission
- Biomarker development for target engagement
Emerging Approaches:
- Brain-penetrant small molecules (e.g., DDR1 inhibitors with DRP1 effects)
- Antibody-based targeting of mitochondrial proteins
- Cell-type specific delivery via AAV capsids
- Nanoparticle-based mitochondrial targeting
- Circulating cell-free mtDNA
- Mitochondrial-derived peptides
- Extracellular vesicle mitochondrial proteins
- Metabolic signatures in plasma
- PET probes for mitochondrial function
- MR spectroscopy of mitochondrial metabolites
- Super-resolution microscopy of blood cell mitochondria
- Fluorescence-based fission reporters
- Platelet mitochondrial morphology
- Lymphoblast mitochondrial dynamics
- Seahorse assay for bioenergetics
- Mitochondrial stress test outcomes
Classical Metrics:
- Aspect ratio (length/width)
- Branching index
- Network connectivity
- Fragmentation index
Advanced Techniques:
- Super-resolution STED microscopy
- 3D electron microscopy reconstruction
- Live-cell STED imaging
- Machine learning-based classification
| Parameter |
Measurement |
Disease Relevance |
| DRP1 Ser616-P |
Western blot/ELISA |
Fission activation |
| DRP1 Ser637-P |
Western blot/ELISA |
Fission inhibition |
| OPA1 long/short ratio |
Gel electrophoresis |
Fusion capacity |
| FIS1 levels |
qPCR/Western |
Fission adaptor |
| MFF levels |
qPCR/Western |
Fission adaptor |
- Mitochondrial membrane potential (TMRE, JC-1)
- ATP/ADP ratio (bioluminescence)
- ROS production (MitoSOX)
- Calcium handling (Fura-2)
- Mitochondrial respiration (Seahorse)
Aβ-DRP1 Interaction:
- Aβ oligomers bind to DRP1 directly
- Aβ promotes DRP1 recruitment to mitochondria
- Aβ-induced ROS activate fission
- Synaptic mitochondria lose fission capacity
Tau-DRP1 Interaction[@manczak2024]:
- Phosphorylated tau binds DRP1
- Tau pathology increases fission frequency
- Synaptic mitochondrial loss precedes tau tangle formation
- DRP1 inhibition protects against Aβ toxicity
Therapeutic Implications:
- Dual targeting of Aβ and mitochondrial fission
- DRP1 inhibitors in early AD prevention
- Fission modulation alongside anti-amyloid therapies
α-Synuclein-DRP1 Interaction[@zhang2025]:
- α-Synuclein oligomers bind TOM20
- α-Synuclein impairs mitochondrial protein import
- Mitochondrial stress promotes fission
- Fission failure leads to mitophagy impairment
PINK1-Parkin Pathway[@park2024]:
- PINK1 accumulates on damaged mitochondria
- Parkin ubiquitinates outer membrane proteins
- DRP1 is recruited for fission
- Fission enables mitophagy completion
Dopaminergic Neuron Vulnerability:
- High energy demand requires robust mitochondria
- Limited fission capacity in SNc neurons
- Age-related decline affects dopamine neurons first
- Fission modulators may protect vulnerable neurons
¶ Animal Models and Experimental Systems
| Model |
Application |
Key Findings |
| Drp1 flox/flox + CamKII-Cre |
Conditional KO |
Fission required for neuronal survival |
| Drp1 heterozygous |
Partial reduction |
Improved mitochondrial morphology in AD models |
| Fis1 overexpression |
Fission increase |
Accelerated neurodegeneration |
| Mff knockout |
Fission loss |
Defective mitophagy, accumulation |
- Mdivi-1 treatment: DRP1 inhibition in vivo
- CCCP treatment: Mitochondrial depolarization
- Oligomycin: ATP synthase inhibition
- Rotenone Complex I inhibition
- Patient-derived neurons with mitochondrial mutations
- Isogenic controls for variant analysis
- Differentiated dopaminergic neurons from PD patients
- Cortical neurons from AD patients
Oxidative Stress:
- ROS promote DRP1 activation
- Fission increases in response to oxidative damage
- Fragmentation is protective by isolating damaged segments
- Antioxidants reduce fission frequency
Energy Stress:
- AMPK activation promotes fission
- ATP depletion triggers fission for quality control
- Fission enables mitophagy under stress
- Metabolic compromise accelerates fission
Inflammatory Stress:
- Cytokines modulate DRP1 expression
- Microglial activation affects neuronal fission
- NF-κB regulates fission protein transcription
- Inflammasome activation intersects with dynamics
- Cytochrome c release requires fission
- Fission enables proper apoptotic execution
- DRP1 cleavage by caspases in apoptosis
- Anti-apoptotic Bcl-2 family proteins regulate fission
¶ Computational Models and Systems Biology
- Mitochondrial dynamics is governed by ~50 proteins
- Systems biology models predict fission-fusion balance
- Machine learning identifies key regulatory nodes
- Protein-protein interaction networks reveal targets
- Agent-based modeling of fission events
- Quantitative systems pharmacology models
- Single-cell dynamics analysis
- Population-level mitochondrial heterogeneity
¶ Future Directions and Unresolved Questions
- Why are specific neurons vulnerable? — SNc dopaminergic neurons have unique fission requirements
- Optimal intervention timing — When during disease progression should fission be modulated?
- Fission vs. fusion prioritization — Which process is more critical to target?
- Cell-type specificity — Can we achieve neuron-specific targeting?
- Biomarker development — Non-invasive markers of mitochondrial dynamics status
- Single-cell mitochondrial dynamics measurement
- In vivo mitochondrial fission imaging
- Brain-penetrant fission modulators
- Gene therapy for fission protein modulation
- Combination approaches with disease-modifying therapies
Recent advances have clarified the role of mitochondrial fission in neurodegeneration:
-
DRP1 phosphorylation and neuronal vulnerability: Studies reveal that specific DRP1 phosphorylation sites (Ser616, Ser637) differentially regulate mitochondrial fission in neurons, with modulation offering therapeutic potential in Alzheimer's and Parkinson's disease[@kim2025].
-
Mitochondrial fission in tauopathy: Research demonstrates that hyperphosphorylated tau interacts with DRP1, enhancing fission and contributing to synaptic mitochondrial loss in Alzheimer's disease[@manczak2024].
-
Alpha-synuclein and mitochondrial dynamics: Pathological alpha-synuclein directly binds to mitochondrial proteins, including DRP1 and TOM20, disrupting fission/fusion balance and promoting neuronal death in Parkinson's disease[@zhang2025].
-
Therapeutic targeting of fission machinery: Small molecule DRP1 inhibitors (like mdivi-1) have shown neuroprotective effects in preclinical models, though CNS delivery remains challenging[@reddy2024].
-
Fission and mitophagy interplay: Recent work reveals that fission is a prerequisite for mitophagy, with defective fission leading to accumulation of dysfunctional mitochondria in neurodegenerative diseases[@liu2025].
-
ALS pathogenesis: DRP1-mediated mitochondrial fission is elevated in ALS models and patient tissues, with excessive fission contributing to motor neuron vulnerability[@choi2024].
-
Huntington's disease: Mitochondrial dynamics are severely disrupted in HD, with DRP1 hyperactivity contributing to striatal neuron death and fission inhibitors showing protective effects[@iyer2024].
-
PINK1-Parkin pathway: New insights into how PINK1 and Parkin coordinate mitochondrial fission as part of the quality control cascade in PD[@park2024].